Advent Technologies Holdings Inc. [ADN] fell -65.62% so far this year. What now?

Related

Advent Technologies Holdings Inc. [NASDAQ: ADN] traded at a low on 03/24/22, posting a -15.14 loss after which it closed the day’ session at $2.41. The company report on March 21, 2022 that Advent Technologies Announces Date for Fourth Quarter 2021 Earnings Call.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Company to Report Q4 2021 Results on March 28, 2022.

Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent” or the “Company”), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it will release its financial results for the fourth quarter ended December 31, 2021 on Monday, March 28, 2022 and will host a conference call the same day at 9:00 AM ET to discuss its results.

The results of the trading session contributed to over 3704783 shares changing hands. Over the past one week, the price volatility of Advent Technologies Holdings Inc. stands at 15.52% while the volatility over the past one month is 12.58%.

The market cap for ADN stock reached $131.90 million, with 54.73 million shares outstanding and 26.82 million shares in the current float. Compared to the average trading volume of 538.57K shares, ADN reached a trading volume of 3704783 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Advent Technologies Holdings Inc. [ADN]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ADN shares is $25.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ADN stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for Advent Technologies Holdings Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 18, 2021. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on March 19, 2021, representing the official price target for Advent Technologies Holdings Inc. stock.

The Average True Range (ATR) for Advent Technologies Holdings Inc. is set at 0.35, with the Price to Sales ratio for ADN stock in the period of the last 12 months amounting to 31.40. The Price to Book ratio for the last quarter was 0.85, with the Price to Cash per share for the same quarter was set at 1.69.

How has ADN stock performed recently?

Advent Technologies Holdings Inc. [ADN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.25. With this latest performance, ADN shares dropped by -13.62% in over the last four-week period, additionally sinking by -72.58% over the last 6 months – not to mention a drop of -84.43% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADN stock in for the last two-week period is set at 34.03, with the RSI for the last a single of trading hit 31.31, and the three-weeks RSI is set at 34.11 for Advent Technologies Holdings Inc. [ADN]. The present Moving Average for the last 50 days of trading for this stock 3.56, while it was recorded at 2.83 for the last single week of trading, and 7.09 for the last 200 days.

Advent Technologies Holdings Inc. [ADN]: Deeper insight into the fundamentals

Return on Total Capital for ADN is now -1.69, given the latest momentum, and Return on Invested Capital for the company is -105.18. Return on Equity for this stock declined to -105.18, with Return on Assets sitting at -62.65.

Reflecting on the efficiency of the workforce at the company, Advent Technologies Holdings Inc. [ADN] managed to generate an average of -$20,042,796 per employee.Advent Technologies Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.70 and a Current Ratio set at 7.00.

Insider trade positions for Advent Technologies Holdings Inc. [ADN]

There are presently around $39 million, or 33.50% of ADN stock, in the hands of institutional investors. The top three institutional holders of ADN stocks are: BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. with ownership of 3,814,184, which is approximately 17.812% of the company’s market cap and around 47.67% of the total institutional ownership; INVESCO LTD., holding 2,778,867 shares of the stock with an approximate value of $6.7 million in ADN stocks shares; and BLACKROCK INC., currently with $3.54 million in ADN stock with ownership of nearly -0.336% of the company’s market capitalization.

Positions in Advent Technologies Holdings Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 33 institutional holders increased their position in Advent Technologies Holdings Inc. [NASDAQ:ADN] by around 2,893,563 shares. Additionally, 23 investors decreased positions by around 2,004,580 shares, while 6 investors held positions by with 11,484,914 shares. The mentioned changes placed institutional holdings at 16,383,057 shares, according to the latest SEC report filing. ADN stock had 10 new institutional investments in for a total of 738,313 shares, while 9 institutional investors sold positions of 1,202,757 shares during the same period.

[class^="wpforms-"]
[class^="wpforms-"]